Caribou Biosciences (CRBU) Assets (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Assets data on file, last reported at $149.0 million in Q1 2026.

• Assets for Q1 2026 came in at $149.0 million, down 45.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $149.0 million (down 45.55% YoY), and the FY2025 annual result was $175.4 million, down 44.03% from the prior year.
• Assets declined to $149.0 million in Q1 2026 per CRBU's latest filing, from $175.4 million in the prior quarter.
• Over five years, Assets peaked at $457.5 million in Q3 2023 and troughed at $149.0 million in Q1 2026.
• A 5-year average of $334.0 million and a median of $349.6 million in 2023 frame the typical range for Assets.
• The sharpest annual moves came in 2022 and 2026: Assets jumped 166.02% in 2022, then slumped 45.55% in 2026.
• A 5-year view of Assets shows it stood at $373.8 million in 2022, then climbed by 15.64% to $432.2 million in 2023, then dropped by 27.51% to $313.3 million in 2024, then tumbled by 44.03% to $175.4 million in 2025, then retreated by 15.04% to $149.0 million in 2026.
• Business Quant data shows CRBU's Assets at $149.0 million in Q1 2026, $175.4 million in Q4 2025, and $195.0 million in Q3 2025.